Cellectar Biosciences
CLRB
CLRB
30 hedge funds and large institutions have $4.69M invested in Cellectar Biosciences in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 10
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$646K | |
| 2 | +$173K | |
| 3 | +$41.5K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.36K |
| 5 |
Renaissance Technologies
New York
|
+$4.73K |
Top Sellers
| 1 | -$184K | |
| 2 | -$143K | |
| 3 | -$109K | |
| 4 |
Two Sigma Advisers
New York
|
-$69K |
| 5 |
Two Sigma Investments
New York
|
-$43K |